Page last updated: 2024-08-17

mannitol and Minimal Disease, Residual

mannitol has been researched along with Minimal Disease, Residual in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Antunes, E; Davis, HL; de Boer, K; Greenberg, PD; Heit, W; Hol, S; Kuball, J; Lotz, C; Theobald, M; van Dorp, S; Vicari, AP; Wagner, E; Wattad, M; Weeratna, RD	1

Trials

1 trial(s) available for mannitol and Minimal Disease, Residual

Article	Year
Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909. Cancer immunology, immunotherapy : CII, 2011, Volume: 60, Issue:2 Topics: Adolescent; Antigens, Neoplasm; Cancer Vaccines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Humans; Leukemia, Myeloid, Acute; Male; Mannitol; Mucin-1; Multiple Myeloma; Myeloblastin; Neoplasm Staging; Neoplasm, Residual; Oleic Acids; Oligodeoxyribonucleotides; Peptides; Pilot Projects; Treatment Outcome; WT1 Proteins	2011

Article

Year

Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909.

Cancer immunology, immunotherapy : CII, 2011, Volume: 60, Issue:2

Topics: Adolescent; Antigens, Neoplasm; Cancer Vaccines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Humans; Leukemia, Myeloid, Acute; Male; Mannitol; Mucin-1; Multiple Myeloma; Myeloblastin; Neoplasm Staging; Neoplasm, Residual; Oleic Acids; Oligodeoxyribonucleotides; Peptides; Pilot Projects; Treatment Outcome; WT1 Proteins

2011